Home > Compound List > Product Information
3-Methylpiperidine_Molecular_structure_CAS_626-56-2)
Click picture or here to close

3-Methylpiperidine

Catalog No. 68850 Name Sigma Aldrich
CAS Number 626-56-2 Website http://www.sigmaaldrich.com
M. F. C6H13N Telephone 1-800-521-8956
M. W. 99.17412 Fax
Purity ≥98.0% (GC) Email
Storage Chembase ID: 50211

SYNONYMS

Title
3-甲基哌啶
IUPAC name
3-methylpiperidine
IUPAC Traditional name
3-methylpiperidine
Synonyms
β-甲基哌啶
3-哌可啉
3-Pipecoline
β-Pipecoline

DATABASE IDS

CAS Number 626-56-2
Beilstein Number 79807
EC Number 210-953-6
MDL Number MFCD00005994
PubChem SID 24885854

PROPERTIES

Empirical Formula (Hill Notation) C6H13N
Grade purum
Purity ≥98.0% (GC)
Boiling Point 125-126 °C/763 mmHg(lit.)
Density 0.845 g/mL at 25 °C(lit.)
Flash Point 21 °C
Flash Point 69.8 °F
Refractive Index n20/D 1.447(lit.)
Refractive Index n20/D 1.448
GHS Pictograms GHS02
GHS Pictograms GHS07
GHS Signal Word Danger
GHS Hazard statements H225-H315-H319-H335
European Hazard Symbols Flammable Flammable (F)
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
Personal Protective Equipment Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
GHS Precautionary statements P210-P261-P305 + P351 + P338
RID/ADR UN 1993 3/PG 2
Risk Statements 11-36/37/38
Safety Statements 16-23
Hazard Class 3
UN Number 1993
Packing Group 2
German water hazard class 3

DETAILS

Description (English)
Caution
may discolor to yellow on storage
Application
Reactant for synthesis of:
• Phenylpropenamide derivatives for anti-hepatitis B virus activity1
• CB2 receptor agonists for treatment of chronic pain2
• Aurora kinase inhibitors3
• Spiroimidazolidinone NPC1L1 inhibitors4
• 1,3,5-Oxadiazinones5
• Selective serotonin 5-HT6 receptor antagonists6
Description (简体中文)
Caution
储存时可变为黄色
Application
Reactant for synthesis of:
• Phenylpropenamide derivatives for anti-hepatitis B virus activity1
• CB2 receptor agonists for treatment of chronic pain2
• Aurora kinase inhibitors3
• Spiroimidazolidinone NPC1L1 inhibitors4
• 1,3,5-Oxadiazinones5
• Selective serotonin 5-HT6 receptor antagonists6

REFERENCES